Inverse Effects on Gating and Modulation Caused by a Mutation in the M2-M3 Linker of the GABAA Receptor γ Subunit

  1. Sean M. O'Shea1,
  2. Carrie A. Williams and
  3. Andrew Jenkins
  1. Department of Anesthesiology, Emory University University School of Medicine, Atlanta, Georgia
  1. Address correspondence to:
    Dr. Sean M. O'Shea, Department of Molecular Neurogenetics, Max Planck Institute of Biophysics, Max-von-Laue-Strasse 3, D-60438 Frankfurt am Main, Germany. E-mail: sean.oshea{at}mpibp-frankfurt.mpg.de

Abstract

M2-M3 linkers are receptor subunit domains known to be critical for the normal function of cysteine-loop ligand-gated ion channels. Previous studies of α and β subunits of type “A” GABA receptors suggest that these linkers couple extracellular elements involved in GABA binding to the transmembrane segments that control the opening of the ion channel. To study the importance of the γ subunit M2-M3 linker, we examined the macroscopic and single-channel effects of an engineered γ2(L287A) mutation on GABA activation and propofol modulation. In the macroscopic analysis, we found that the γ2(L287A) mutation decreased GABA potency but increased the ability of propofol to enhance both GABA potency and efficacy compared with wild-type receptors. Indeed, although propofol had significant effects on GABA potency in wild-type receptors, we found that propofol produced no corresponding increase in GABA efficacy. At the single-channel level, mutant receptors showed a loss in the longest of three open-time components compared with wild-type receptors under GABA activation. Furthermore, propofol reduced the duration of one closed-time component, increased the duration of two open-time components, and generated a third open component with a longer lifetime in mutant compared with wild-type receptors. Taken together, we conclude that although the γ subunit is not required for the binding of GABA or propofol, the M2-M3 linker of this subunit plays a critical role in channel gating by GABA and allosteric modulation by propofol. Our results also suggest that in wild-type receptors, propofol exerts its enhancing effects by mechanisms extrinsic to channel gating.

Footnotes

  • This work was supported by the National Institutes of Health National Institute of General Medical Sciences [Grant GM073959].

  • ABBREVIATIONS: PRO, propofol; GABAAR, type A GABA receptor; WT, wild-type α1β1γ2 GABAAR; MUT, mutant α1β1γ2(L278A) type A GABA receptor; M2-M3 linker, extracellular domain joining transmembrane domains 2 and 3; LGIC, ligand-gated ion channel; DMEM, Dulbecco's modified Eagle's medium; ϵ, relative efficacy; tcrit, critical time; C, closed; O, open.

  • Graphic The online version of this article (available at http://molpharm.aspetjournals.org) contains supplemental material.

  • 1 Current affiliation: Department of Molecular Neurogenetics, Max Planck Institute of Biophysics, Frankfurt am Main, Germany.

    • Accepted June 24, 2009.
    • Received February 2, 2009.
« Previous | Next Article »Table of Contents

This Article

  1. Molecular Pharmacology September 2009 vol. 76 no. 3 641-651
  1. » Abstract
  2. Full Text
  3. Full Text (PDF)
  4. Data Supplement
  5. All Versions of this Article:
    1. mol.109.055111v1
    2. 76/3/641 most recent

Classifications

Responses

  1. Submit a response
  2. No responses published